000 | 01338 a2200409 4500 | ||
---|---|---|---|
005 | 20250515182329.0 | ||
264 | 0 | _c20090924 | |
008 | 200909s 0 0 rus d | ||
022 | _a0022-9040 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBatyraliev, T A | |
245 | 0 | 0 |
_a[Safety and efficacy of the use of glycoprotein IIb/IIIa inhibitors in the invasive treatment of patients with ST-elevation acute coronary syndrome]. _h[electronic resource] |
260 |
_bKardiologiia _c2009 |
||
300 |
_a4-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Randomized Controlled Trial | ||
650 | 0 | 4 |
_aAcute Coronary Syndrome _xdrug therapy |
650 | 0 | 4 | _aAngioplasty, Balloon, Coronary |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 | _aElectrocardiography |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPlatelet Glycoprotein GPIIb-IIIa Complex _xantagonists & inhibitors |
650 | 0 | 4 | _aStents |
650 | 0 | 4 | _aThrombolytic Therapy |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTirofiban |
650 | 0 | 4 |
_aTyrosine _xadverse effects |
700 | 1 | _aFettser, D V | |
700 | 1 | _aVural, A | |
700 | 1 | _aPershukov, I V | |
700 | 1 | _aPreobrazhenskiĭ, D V | |
700 | 1 | _aAvşar, O | |
700 | 1 | _aSidorenko, B A | |
773 | 0 |
_tKardiologiia _gvol. 49 _gno. 6 _gp. 4-9 |
|
999 |
_c19062996 _d19062996 |